Last reviewed · How we verify
Anaerobic Joint Infection
Approved treatments
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Anaerobic Joint Infection patent landscape — cliff calendar, originator estates, attackable patents
- Anaerobic Joint Infection treatment landscape brief
- Anaerobic Joint Infection treatment updates RSS
Frequently asked questions about Anaerobic Joint Infection
What drugs treat Anaerobic Joint Infection?
Tracked treatments include Cleocin T, Cleocin.
What is the treatment for Anaerobic Joint Infection?
Standard treatment for Anaerobic Joint Infection includes Cleocin T, Cleocin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Anaerobic Joint Infection patent cliff · Anaerobic Joint Infection CI report
- Treatment: Cleocin T · Pfizer
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing